Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
La Jolla Pharmaceutical Co (LJPC US)
Watchlist
1
Analysis
Health Care
•
United States
La Jolla Pharmaceutical Company researches and develops specialized therapeutics for the treatment of diseases caused by antibodies. The Company is developing products to treat autoimmune conditions such as lupus and antibody-mediated stroke.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
14 Feb 2023 18:06
US SEC Form SC 13G/A for La Jolla Pharmaceutical Co
Attachment
Exchange Announcement •
01 Sep 2022 16:38
US SEC Form 15-12G for La Jolla Pharmaceutical Co
Attachment
Exchange Announcement •
29 Aug 2022 20:30
US SEC Form SC 13D/A for La Jolla Pharmaceutical Co
Attachment
Exchange Announcement •
29 Aug 2022 20:07
US SEC Form SC 13D for La Jolla Pharmaceutical Co
Attachment
Exchange Announcement •
25 Aug 2022 04:27
Statement of changes in beneficial ownership of securities - general instructions (PDF)
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3
x